XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Cash and cash equivalents    
Restricted cash $ 427 $ 514
Accumulated depreciation and amortization 10,739 9,911
Other assets, reserves for credit losses 27 27
Liabilities    
Long-term debt $ 49,715 $ 47,866
Shareholders’ Equity    
Preferred shares, par value (in dollars per share) $ 1.667 $ 1.667
Preferred shares, authorized (in shares) 20,000,000 20,000,000
Preferred shares, issued (in shares) 1,600 1,600
Preferred shares, outstanding (in shares) 1,600 1,600
Common shares, par value (in dollars per share) $ 0.20 $ 0.20
Common shares, authorized (in shares) 3,600,000,000 3,600,000,000
Common shares, issued (in shares) 702,000,000 723,000,000
Common shares, outstanding (in shares) 702,000,000 723,000,000
Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross $ 59,411 $ 60,411
Allowance for credit losses 171 174
Card Member loans    
Cash and cash equivalents    
Financing receivables, gross 139,674 125,995
Allowance for credit losses 5,679 5,118
Other Loans    
Cash and cash equivalents    
Allowance for credit losses 194 126
Variable Interest Entity, Primary Beneficiary    
Cash and cash equivalents    
Restricted cash 6 0
Restricted investments 82 66
Liabilities    
Long-term debt 13,880 13,426
Variable Interest Entity, Primary Beneficiary | Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross 3,927 4,587
Variable Interest Entity, Primary Beneficiary | Card Member loans    
Cash and cash equivalents    
Financing receivables, gross $ 28,278 $ 28,590